Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06510803 · ClinicalTrials.gov registry record
Sevoflurane Concentrations in Children
A clinical trial, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 24
- Enrollment target
NCT06510803: Completed study, sponsored by State University of New York at Buffalo.
NCT06510803 is a clinical trial that has completed, run by State University of New York at Buffalo. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06510803 has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The sevoflurane concentrations (as well as vital signs, child's date of birth, type of surgery) will be recorded during the first 10 minutes of anesthesia.
Primary Outcome
We will measure the inspired and expired sevoflurane concentrations using an agent monitor, determine the ratio for each patient during each measurement at 30 seconds for the first 5 minutes of induction and and then every minute until the IV is secured. Data are reported as means and standard deviations at each of the time points and represented in a figure.
Interventions
- DRUG The washin of sevoflurane in the GE Ohmeda workstation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-09-18 |
| Est. Completion | 2024-10-24 |
What the finished NCT06510803 record still lists
NCT06510803 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which The washin of sevoflurane in the GE Ohmeda workstation is the first listed.
NCT06510803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06510803 about?
NCT06510803 is a clinical study titled "Sevoflurane Concentrations in Children". The sevoflurane concentrations (as well as vital signs, child's date of birth, type of surgery) will be recorded during the first 10 minutes of anesthesia.
What is the current status of trial NCT06510803?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2024-09-18. Estimated completion is 2024-10-24.
What interventions are being tested in trial NCT06510803?
The interventions under investigation include: The washin of sevoflurane in the GE Ohmeda workstation (DRUG).
Who is sponsoring clinical trial NCT06510803?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI